| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |